KLRA — Kailera Therapeutics, Inc. stock price, charts and financials

QT14Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. (NASDAQ: KLRA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
18.11
+0.79+4.56%
OverviewShort InterestFilings
KLRAQT14Kailera Therapeutics, Inc.·NASDAQ
18.11+4.56%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20263Initial statement of beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
May 26, 20268-KCurrent report
May 26, 202610-QQuarterly report
Apr 23, 2026SC 13DBeneficial ownership statement (active)
Apr 23, 2026SC 13DBeneficial ownership statement (active)
Apr 22, 20264Statement of changes in beneficial ownership
Apr 22, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20268-KCurrent report
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
#1 / 25 of 52
Page
▼
/ 3